Perkins KJ - Search Results

1

Transcription-dependent gene looping of the HIV-1 provirus is dictated by recognition of pre-mRNA processing signals.

Perkins KJ, Lusic M, Mitar I, Giacca M, Proudfoot NJ. Perkins KJ, et al. Mol Cell. 2008 Jan 18;29(1):56-68. doi: 10.1016/j.molcel.2007.11.030. Mol Cell. 2008. PMID: 18206969 Free PMC article.

2

An ungracious host for an unwelcome guest.

Perkins KJ, Proudfoot NJ. Perkins KJ, et al. Cell Host Microbe. 2008 Aug 14;4(2):89-91. doi: 10.1016/j.chom.2008.07.010. Cell Host Microbe. 2008. PMID: 18692766 Free article.

3

Ets-2 repressor factor silences extrasynaptic utrophin by N-box mediated repression in skeletal muscle.

Perkins KJ, Basu U, Budak MT, Ketterer C, Baby SM, Lozynska O, Lunde JA, Jasmin BJ, Rubinstein NA, Khurana TS. Perkins KJ, et al. Mol Biol Cell. 2007 Aug;18(8):2864-72. doi: 10.1091/mbc.e06-12-1069. Epub 2007 May 16. Mol Biol Cell. 2007. PMID: 17507653 Free PMC article.

4

Ets, Ap-1 and GATA factor families regulate the utrophin B promoter: potential regulatory mechanisms for endothelial-specific expression.

Perkins KJ, Davies KE. Perkins KJ, et al. FEBS Lett. 2003 Mar 13;538(1-3):168-72. doi: 10.1016/s0014-5793(03)00175-3. FEBS Lett. 2003. PMID: 12633873 Free article.

5

The role of basal and myogenic factors in the transcriptional activation of utrophin promoter A: implications for therapeutic up-regulation in Duchenne muscular dystrophy.

Perkins KJ, Burton EA, Davies KE. Perkins KJ, et al. Nucleic Acids Res. 2001 Dec 1;29(23):4843-50. doi: 10.1093/nar/29.23.4843. Nucleic Acids Res. 2001. PMID: 11726694 Free PMC article.

6

Prediction of Sanfilippo phenotype severity from immunoquantification of heparan-N-sulfamidase in cultured fibroblasts from mucopolysaccharidosis type IIIA patients.

Perkins KJ, Muller V, Weber B, Hopwood JJ. Perkins KJ, et al. Mol Genet Metab. 2001 Aug;73(4):306-12. doi: 10.1006/mgme.2001.3190. Mol Genet Metab. 2001. PMID: 11509012

7

The role of utrophin in the potential therapy of Duchenne muscular dystrophy.

Perkins KJ, Davies KE. Perkins KJ, et al. Neuromuscul Disord. 2002 Oct;12 Suppl 1:S78-89. doi: 10.1016/s0960-8966(02)00087-1. Neuromuscul Disord. 2002. PMID: 12206801 Review.

8

Therapeutics for Duchenne muscular dystrophy: current approaches and future directions.

Bogdanovich S, Perkins KJ, Krag TO, Khurana TS. Bogdanovich S, et al. Among authors: perkins kj. J Mol Med (Berl). 2004 Feb;82(2):102-15. doi: 10.1007/s00109-003-0484-1. Epub 2003 Dec 12. J Mol Med (Berl). 2004. PMID: 14673527 Review.

9

Myostatin propeptide-mediated amelioration of dystrophic pathophysiology.

Bogdanovich S, Perkins KJ, Krag TO, Whittemore LA, Khurana TS. Bogdanovich S, et al. Among authors: perkins kj. FASEB J. 2005 Apr;19(6):543-9. doi: 10.1096/fj.04-2796com. FASEB J. 2005. PMID: 15791004

10

Alternative utrophin mRNAs contribute to phenotypic differences between dystrophin-deficient mice and Duchenne muscular dystrophy.

Perkins KJ, Davies KE. Perkins KJ, et al. FEBS Lett. 2018 Jun;592(11):1856-1869. doi: 10.1002/1873-3468.13099. Epub 2018 May 30. FEBS Lett. 2018. PMID: 29772070 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters